Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 3
2015 1
2016 1
2019 1
2021 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year

Filters applied: . Clear all
Page 1
Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial.
Heerspink HJL, Parving HH, Andress DL, Bakris G, Correa-Rotter R, Hou FF, Kitzman DW, Kohan D, Makino H, McMurray JJV, Melnick JZ, Miller MG, Pergola PE, Perkovic V, Tobe S, Yi T, Wigderson M, de Zeeuw D; SONAR Committees and Investigators. Heerspink HJL, et al. Lancet. 2019 May 11;393(10184):1937-1947. doi: 10.1016/S0140-6736(19)30772-X. Epub 2019 Apr 14. Lancet. 2019. PMID: 30995972 Clinical Trial.
Combination Treatment with Verinurad and Allopurinol in CKD: A Randomized Placebo and Active Controlled Trial.
Heerspink HJL, Stack AG, Terkeltaub R, Jongs N, Inker LA, Bjursell M, Maklad N, Perl S, Eklund O, Rikte T, Sjöström CD, Perkovic V; SAPPHIRE Investigators. Heerspink HJL, et al. J Am Soc Nephrol. 2024 May 1;35(5):594-606. doi: 10.1681/ASN.0000000000000326. Epub 2024 Feb 20. J Am Soc Nephrol. 2024. PMID: 38564654 Clinical Trial. No abstract available.
Current clinical practice in adapted automated peritoneal dialysis (aAPD)-A prospective, non-interventional study.
Vera M, Cheak BB, Chmelíčková H, Bavanandan S, Goh BL, Abdul Halim AG, Garcia I, Gajdoš M, Alonso Valente R, De Los Ríos T, Atiye S, Stauss-Grabo M, Galli E. Vera M, et al. Among authors: chmelickova h. PLoS One. 2021 Dec 9;16(12):e0258440. doi: 10.1371/journal.pone.0258440. eCollection 2021. PLoS One. 2021. PMID: 34882678 Free PMC article. Clinical Trial.
Ghrelin variants influence development of body mass index and plasma levels of total cholesterol in dialyzed patients.
Hubacek JA, Bloudícková S, Bohuslavová R, Táborský P, Polakovic V, Sazamová M, Svítilová E, Vlasák J, Sojková I, Ryba M, Knetl P, Ullrych M, Drahozal R, Pavuková V, Pavlíková B, Fischlová D, Mokrejsová M, Chmelícková H, Pauchová E, Vyskocil P, Nýdlová Z, Kopenec J, Fixa P, Hajný J, Bubenícek P, Syrovátka P, Zahálková J, Surel S, Hobzek Z, Hrubý A, Suchanová J, Vanková S, Brabcová J, Viklický O; MIA Group. Hubacek JA, et al. Among authors: chmelickova h. Clin Chem Lab Med. 2007;45(9):1121-3. doi: 10.1515/CCLM.2007.141. Clin Chem Lab Med. 2007. PMID: 17635077
The effect of CCR2 inhibitor CCX140-B on residual albuminuria in patients with type 2 diabetes and nephropathy: a randomised trial.
de Zeeuw D, Bekker P, Henkel E, Hasslacher C, Gouni-Berthold I, Mehling H, Potarca A, Tesar V, Heerspink HJ, Schall TJ; CCX140-B Diabetic Nephropathy Study Group. de Zeeuw D, et al. Lancet Diabetes Endocrinol. 2015 Sep;3(9):687-96. doi: 10.1016/S2213-8587(15)00261-2. Epub 2015 Aug 9. Lancet Diabetes Endocrinol. 2015. PMID: 26268910 Clinical Trial.